You are viewing: US Dental Bone Graft Substitutes Market analysis

The US Dental Bone Graft Substitutes Market was valued at $58.25 Million in 2026 and projected to reach to $93.71 Million by 2031, representing a compound annual growth rate of 10.0%. The US dental bone graft substitutes market is positioned for sustained expansion through 2031, driven by technological advancements in regenerative materials and increasing patient demand for tooth replacement solutions.

US Dental Bone Graft Substitutes Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Dental Bone Graft Substitutes Market Trends and Insights

  • This 10.0% compound annual growth rate significantly outpaces the global average, reflecting strong demand within the US healthcare system for advanced dental regenerative solutions.
  • The US market benefits from high adoption rates of innovative dental technologies, increasing prevalence of periodontal disease, and rising patient awareness of bone grafting procedures. Driving this expansion, the US dental sector is witnessing increased investment in implant dentistry and reconstructive procedures.
  • The US market's growth trajectory is supported by favorable reimbursement policies, a well-established dental infrastructure, and the presence of leading manufacturers.
  • Between 2026 and 2031, the US is expected to capture significant market share as dental professionals increasingly integrate bone graft substitutes into routine clinical practice. The competitive landscape in the US remains dynamic, with both established players and emerging innovators competing to capture market opportunities.
  • The US regulatory environment, governed by the FDA, ensures product quality and safety, further bolstering consumer confidence and market expansion through 2031..

Key Market Statistics

  • CAGR (2026-2031) 10.0% CAGR
  • Market Size, 2026 ~USD 58.25 Million
  • Forecast, 2031 ~USD 93.71 Million
  • Country US

US Dental Bone Graft Substitutes Market Overview

Market Size & Growth :

The US dental bone graft substitutes market is valued at $58.25 million in 2026 and is projected to reach $93.71 million by 2031, representing a robust 10% CAGR that significantly exceeds the global average of 7.1%.

High Adoption Rates :

US dental practitioners demonstrate strong adoption of advanced regenerative solutions, driven by sophisticated healthcare infrastructure, high patient awareness, and favorable reimbursement policies for dental implant procedures.

Regulatory Environment :

The FDA's established approval pathways for bone graft substitutes and the US emphasis on clinical evidence support rapid innovation and market entry for new dental regenerative products in the American market.

Clinical Demand Drivers :

Rising prevalence of tooth loss, increased cosmetic dentistry demand, aging population demographics, and growing preference for implant-based solutions are fueling consistent demand for bone graft substitutes across US dental practices.

US Dental Bone Graft Substitutes Market Dynamics

  • The market's 10% CAGR reflects strong healthcare spending, high procedural adoption rates, and favorable insurance coverage for dental implants.
  • Key growth catalysts include an aging population requiring restorative dentistry, rising cosmetic dental procedures, and continuous innovation in synthetic and natural bone graft alternatives.
  • The US market's outperformance versus global trends underscores the country's advanced dental infrastructure and patient purchasing power..

Related Ecosystem

Dental Devices

Top Technologies
  • Dental Implants
  • Dental Bone Grafts
  • Dental Crowns
  • Dental Prosthetics
  • Zirconium Implants
Top Companies
  • DENTSPLY SIRONA Inc.
  • Henry Schein, Inc.
  • KAVO KERR GROUP
  • PLANMECA GROUP
  • Patterson Companies, Inc.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • The US dental bone graft substitutes market is valued at $58.25 million in 2026 and will reach $93.71 million by 2031, representing a 10.0% CAGR.
      • The US market growth rate significantly exceeds the global 7.1% CAGR, driven by advanced healthcare infrastructure and high implant adoption rates.
      • Favorable US reimbursement policies and FDA regulatory oversight support market expansion and consumer confidence in bone graft substitute products.
      • The US dental sector's focus on implant dentistry and reconstructive procedures will continue to drive demand for bone graft substitutes through 2031.

      Dental Bone Graft Substitutes Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment SINUS LIFT (Application)
      Forecast Period 2026–2031
      Growth Rate CAGR of 7.1% from 2026 to 2031
      Largest Segment DENTAL HOSPITALS (End User)
      Market Size Base Year (Billions) ~USD 0.72 (2026)
      Revenue Forecast (Billions) ~USD 1.01 (2031)
      Segments Covered Type, Application, Mechanism, End User

      US Dental Bone Graft Substitutes Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Type

      • Allografts
      • Dbm
      • Other Allografts
      • Other Dental Bone Graft Substitutes
      • Synthetic Bone Grafts
      • Xenografts

      By Application

      • Implant Bone Regeneration
      • Periodontal Defect Regeneration
      • Ridge Augmentation
      • Sinus Lift
      • Socket Preservation

      By Mechanism

      • Osteoconduction
      • Osteogenesis
      • Osteoinduction
      • Osteopromotion

      By End User

      • Dental Clinics
      • Dental Hospitals
      • Other End Users

      US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2024–2031

      Segment20242025202620272028202920302031CAGR (%)
      DENTAL CLINICS87.693.0398.6104.88112.02120.14130.09140.837.4
      DENTAL HOSPITALS111.74119.68127.98137.35148160.14174.93191.068.3
      OTHER END USERS13.5114.0314.5315.1115.7716.5317.4918.515
      TOTAL212.8226.7241.1257.3275.8296.8322.5350.47.8

      Target Audience

      • Dental Device Manufacturers : Manufacturers need US-specific market data to assess market size, competitive positioning, growth potential, and regulatory requirements for launching or expanding bone graft substitute product lines in America's high-value dental market.
      • Healthcare Investment Firms : Private equity and venture capital investors require detailed US market forecasts, growth drivers, and competitive analysis to evaluate investment opportunities in dental regenerative companies and identify acquisition targets.
      • Dental Practice Groups & Clinics : Practice administrators and clinical directors need market insights to understand product availability, pricing trends, clinical efficacy data, and reimbursement landscape for bone graft substitutes in their US dental operations.
      • Healthcare Consultants & Strategists : Consultants advising healthcare organizations require comprehensive US market intelligence to develop market entry strategies, competitive positioning recommendations, and growth roadmaps for dental regenerative solutions.
      • Dental Material Suppliers & Distributors : Suppliers and distributors need US market segmentation, demand forecasts, and channel dynamics to optimize inventory management, negotiate supplier contracts, and identify emerging distribution opportunities in the American dental market.

      Key Companies in the US Dental Bone Graft Substitutes Market

      CompanyHQOwnershipStrongest segments
      HOYA CORPORATIONJapanPublic CompanySynthetic Bone Grafts / Alloplast (ceramic fillers, dental),Metallic Implants with integrated grafting use-cases,Other dental biomaterials and adjuncts,
      NOBEL BIOCARESwitzerlandPrivate CompanyXenograft-based grafts (competing with BioOss),Allograft and demineralized grafts (Grafton-adjacent use cases),Synthetic and alloplast grafts (Osteograf-adjacent use cases),
      OSSTEM IMPLANT CO.,LTDSouth KoreaPrivate CompanyXenograft,Allograft,Synthetic Bone Grafts / Alloplast,
      DENTSPLY SIRONA INC.United StatesPublic CompanyXenograft,Allograft,Synthetic Bone Grafts,
      ENVISTAUnited StatesPublic CompanyXenograft-linked biomaterials (BioOss-adjacent competitive set),Allograft and demineralized grafts (Grafton-adjacent competitive set),Synthetic bone grafts,
      ADVANCED MEDICAL SOLUTIONS GROUP PLCUnited KingdomPublic CompanyBiosurgical haemostats used with grafts,Tissue adhesives and wound closure in dental surgery,Internal fixation and clips for oral/maxillofacial,
      ZIMVIE INC.United StatesPrivate CompanyXenograft,Allograft,Synthetic Bone Grafts / Alloplast,
      HENRY SCHEIN, INC.United StatesPublic CompanyXenograft (incl. BioOss distribution),Allograft (incl. Grafton and equivalents),Synthetic Bone Grafts / Alloplast (incl. Osteograf-type products),

      HOYA CORPORATION

      HOYA Corporation is a Japanese public company founded in 1941 that operates with 37,752 employees. The company is a diversified global manufacturer serving multiple industries.

      NOBEL BIOCARE

      Nobel Biocare is a Swiss private company founded in 1981 with 2,552 employees. The company operates in the medical device and healthcare sectors.

      OSSTEM IMPLANT CO.,LTD

      OSSTEM IMPLANT CO.,LTD is a South Korean private company founded in 1997 with 2,817 employees. The company specializes in implant and dental solutions.

      DENTSPLY SIRONA INC.

      DENTSPLY SIRONA INC. is a United States-based public company founded in 2015. The company operates in the dental and healthcare technology industry.

      ENVISTA

      ENVISTA is a United States-based public company founded in 2018 with 12,000 employees. The company operates in the dental and healthcare solutions sector.

      ADVANCED MEDICAL SOLUTIONS GROUP PLC

      Advanced Medical Solutions Group PLC is a United Kingdom-based public company founded in 1991 with 1,800 employees. The company specializes in advanced medical and surgical solutions.

      ZIMVIE INC.

      ZIMVIE INC. is a United States-based private company founded in 2021 with 1,770 employees. The company operates in the medical device and healthcare sector.

      HENRY SCHEIN, INC.

      Henry Schein, Inc. is a United States-based public company founded in 1932 with 25,000 employees. The company is a global distributor of healthcare products and services.

      Reasons to Buy this Report

      • Market-Specific Sizing & Forecasts : Access precise US market valuations ($58.25M in 2026, $93.71M in 2031) with detailed 10% CAGR projections, enabling accurate financial planning and investment decisions specific to the American dental market.
      • Competitive Landscape Intelligence : Understand the US-specific competitive dynamics, key players, market share distribution, and differentiation strategies among dental bone graft substitute manufacturers operating in the American healthcare system.
      • Regulatory & Reimbursement Insights : Gain comprehensive knowledge of FDA approval pathways, insurance coverage policies, and reimbursement trends specific to US dental procedures, critical for market entry and pricing strategies.
      • Growth Opportunity Identification : Identify high-potential segments within the US market, including geographic hotspots, demographic opportunities, and emerging clinical applications driving the 10% CAGR outperformance versus global trends.
      • Strategic Decision Support : Leverage US-focused market data for product development prioritization, distribution channel selection, partnership opportunities, and go-to-market strategies tailored to American dental practitioners and patients.

      Frequently asked questions

      What is the current size of the US dental bone graft substitutes market?

      The US dental bone graft substitutes market is valued at $58.25 million in 2026 and is projected to grow to $93.71 million by 2031.

      What is the growth rate of the US dental bone graft substitutes market?

      The US market is growing at a compound annual growth rate (CAGR) of 10.0% from 2026 to 2031, outpacing the global average of 7.1%.

      What factors are driving growth in the US dental bone graft substitutes market?

      Key drivers include increased implant dentistry adoption, rising periodontal disease prevalence, favorable reimbursement policies, and strong FDA-regulated product quality standards in the US.

      How does the US market compare to the global dental bone graft substitutes market?

      The US market grows at 10.0% CAGR, significantly faster than the global 7.1% CAGR, reflecting the US healthcare system's advanced infrastructure and high technology adoption rates.

      What role does FDA regulation play in the US dental bone graft substitutes market?

      FDA oversight ensures product safety and efficacy in the US, building consumer confidence and supporting market expansion by establishing quality standards that manufacturers must meet.

      RESEARCH METHODOLOGY

      This study involved four major activities to estimate the current size of the dental bone graft substitutes market. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

      Secondary Research

      The secondary research process involved the extensive use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, Companies House documents, investor presentations, and SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the dental bone graft substitutes market. It was also used to obtain important information on key players, market classification and segmentation aligned with industry trends down to the bottom level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from various companies and organizations operating in the dental bone graft substitutes market. The primary sources on the demand side included industry experts, purchasing & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players, and gather insights into key industry trends and market dynamics.

      Dental Bone Graft Substitutes Market 
 Size, and Share

      Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.
      Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
      Note 3: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

      Source: MarketsandMarkets Analysis

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      For the global market value, annual revenues were calculated using revenue mappings of major product manufacturers and OEMs active in the global dental bone graft substitutes market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Also, the global dental bone graft substitutes market was split into various segments and subsegments based on the:

      • List of major players operating in the products market at the regional and/or country level
      • Product mapping of various dental bone graft substitute manufacturers at the regional and/or country level
      • Mapping of annual revenue generated by listed major players from dental bone graft substitutes (or the nearest reported business unit/product category)
      • Revenue mapping of major players to be covered
      • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
      • Summation of the market value of all segments/subsegments to arrive at the global dental bone graft substitutes market

      The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

      Dental Bone Graft Substitutes Market Top Down and Bottom Up Approach

      Data Triangulation

      After determining the overall size of the global dental bone graft substitutes market using the above-mentioned methodology, the market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, where applicable, to complete the overall market engineering process and derive the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.

      Market Definition

      A dental bone graft substitute is a biocompatible material used by dentists to rebuild or augment jawbone tissue lost due to various reasons. These substitutes act as a scaffold or supportive structure to promote the growth of new bone tissue in the jaw. They essentially fill the defect or gap where bone loss has occurred.

      Key Stakeholders

      • Manufacturers and distributors of dental bone graft substitutes
      • Manufacturers and distributors of dental bone graft substitute components
      • Dental bone graft substitute companies
      • Healthcare institutes
      • Diagnostic laboratories
      • Dental hospitals and clinics
      • Academic institutes
      • Research institutes
      • Government associations
      • Market research and consulting firms
      • Venture capitalists and investors

      Report Objectives

      • To define, describe, segment, analyze, and forecast the global dental bone graft substitutes market by type, application, mechanism, product, end user, and region
      • To provide detailed information about the factors influencing the market growth (drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the dental bone graft substitutes market in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players in the dental bone graft substitutes market and comprehensively analyze their core competencies
      • To track and analyze competitive developments such as agreements, collaborations, and partnerships; expansions; acquisitions; and product launches & approvals in the dental bone graft substitutes market

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

      GEOGRAPHIC ANALYSIS

      • Further breakdown of the Rest of Europe dental bone graft substitutes market into Russia, Switzerland, Denmark, Austria, and others
      • Further breakdown of the Rest of Asia Pacific dental bone graft substitutes market into South Korea, Taiwan, and others
      • Further breakdown of the Rest of Latin America dental bone graft substitutes market into Argentina, Colombia, Chile, Ecuador, and others
      • Further breakdown of the Southeast Asia dental bone graft substitutes market into Malaysia, Singapore, New Zealand, and others

      COMPETITIVE LANDSCAPE ASSESSMENT

      • Market share analysis, by region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa), which provides market shares of the top 3–5 key players in the dental bone graft substitutes market
      • Competitive leadership mapping for established players in the US

       

      Get the Full Dental Bone Graft Substitutes Market Report

      Full forecast, segment splits, and company analysis for all Dental Bone Graft Substitutes Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status